Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-09-08FDA Approved: FLECAINIDE ACETATE — Original Application (Epic Pharma, LLC)
FDA approved the original application for flecainide acetate tablets from Epic Pharma, LLC under ANDA215599.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Evaluating Active Esophageal Cooling During Cardiac Ablation Procedures [NA]
This clinical trial completed evaluation of active esophageal cooling during cardiac ablation procedures for atrial fibrillation, with resul…
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating safety and efficacy of tocotrienols for post-CABG atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Atrial Fibrillation Algorithms Clinical Validation Study [NA]
Clinical validation study results for atrial fibrillation detection algorithms sponsored by Apple have been completed and results posted.
-
FDA approval · 2022-08-23FDA Approved: WARFARIN SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Warfarin sodium submitted by Amneal Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved Slate Run Pharmaceuticals' generic diltiazem hydrochloride under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery [NA]
Clinical trial on tragus stimulation to prevent atrial fibrillation after cardiac surgery has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation [Phase 3]
Phase 3 clinical trial investigating colchicine to reduce atrial fibrillation recurrence after ablation.
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients [Phase 4]
Phase 4 trial update on isolating pulmonary veins with PVAC GOLD in elderly patients with atrial fibrillation and cardiac arrhythmias.
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies [Phase 4]
Phase 4 trial examining the pharmacodynamic effects of low-dose rivaroxaban in combination with antiplatelet therapies; results completed wi…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation [Phase 4]
Phase 4 trial update on very high power ablation in patients with atrial fibrillation undergoing first pulmonary vein isolation has complete…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants [Phase 3]
Phase 3 trial updates on tooth extraction in patients with atrial fibrillation using new oral anticoagulants, completed.
-
FDA approval · 2022-06-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Lifestar Pharma LLC)
FDA approves a generic Verapamil Hydrochloride product from Lifestar Pharma LLC under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology [NA]
Clinical trial update for WATCHMAN FLX LAA closure device evaluating its use in atrial fibrillation; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Henagliflozin in Patients With Atrial Fibrillation [Phase 3]
Phase 3 clinical trial update for henagliflozin in patients with atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Digital Flu Intervention for People With Cardiovascular Conditions [NA]
A completed clinical trial evaluating a digital flu intervention for people with cardiovascular conditions, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients [Phase 4]
Open-label Phase 4 trial evaluating EZYPRO® for detecting atrial fibrillation in patients with embolic stroke of undetermined source (ESUS).
-
FDA approval · 2022-05-05FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE — Original Application (Dr. Reddy's Labratories Inc.)
FDA approves Dr. Reddy's Laboratories' generic diltiazem hydrochloride extended-release tablet (ANDA 215775).
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation [NA]
Clinical trial update for AcQMap technique to visualize causes of recurrent atrial fibrillation after failed ablation; study completed with …
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial [Phase 2]
Phase 2 trial update for rivaroxaban in valvular heart disease with atrial fibrillation (RIVER trial) has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Start or STop Anticoagulants Randomised Trial (SoSTART) [Phase 3]
A Phase 3 trial evaluating start or stop anticoagulants in patients with various intracranial hemorrhage contexts and atrial fibrillation/fl…
-
CLINICAL_TRIALS withdrawal · 2022-04-07Clinical Trial Update: Post-operative Corticosteroid Treatment After Mitral Valve Surgery [Phase 2, Phase 3]
A clinical trial investigating post-operative corticosteroid treatment after mitral valve surgery has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Japanese Pradaxa PMS, Long Term
Long-term Japanese Pradaxa post-marketing surveillance trial for atrial fibrillation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection
Clinical trial update on BIOMONITOR utility for identifying atrial fibrillation in ablation candidates; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Shared Decision-Making: AFib 2gether Mobile App [NA]
Clinical trial update for the AFib 2gether mobile app study, completed with posted results.